RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel patients with previously treated gastric or gastroesophageal junction (GEJ) adenocarcinoma: Quality-of-life (QoL) results.

Author:

Al-Batran Salah-Eddin1,Van Cutsem Eric2,Oh Sang Cheul3,Bodoky Gyorgy4,Shimada Yasuhiro5,Hironaka Shuichi6,Sugimoto Naotoshi7,Lipatov Oleg N.8,Kim Tae-You9,Cunningham David10,Rougier Philippe11,Muro Kei12,Liepa Astra M.13,Ballal Shaila14,Emig Michael15,Ohtsu Atsushi16,Wilke Hansjochen17

Affiliation:

1. Krankenhaus Nordwest, Frankfurt, Germany

2. University Hospitals Gasthuisberg, Leuven, Belgium

3. Korea University Guro Hospital, Seoul, South Korea

4. Szent László Hospital, Budapest, Hungary

5. Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

6. Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan

7. Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

8. Bashkortostan Clinical Oncology Center, Ufa, Russia

9. Department of Internal Medicine and Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea

10. Royal Marsden Hospital, Sutton, United Kingdom

11. Hopital Europeen Georges Pompidou, Université Paris V, France, Paris, France

12. Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

13. Eli Lilly and Company, Indianapolis, IN

14. ImClone Systems, Bridgewater, NJ

15. Eli Lilly and Company, Heidelberg, Germany

16. Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Japan

17. Kliniken Essen Mitte Center of Pallative Care, Essen, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3